Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
FDA approves new Kisunla dosing regimen to lower ARIA-E risk
https://alzheimersnewstoday.com/news/fda-approves-new-kisunla-dosing-regimen-lower-aria-e-risk/
links
backlinks
Tagged with:
news
fda approval
donanemab
aria-e
A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug Administration.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
